ARTICLE | Company News
Avanir Pharmaceuticals, Schering-Plough deal
January 28, 2002 8:00 AM UTC
AVN subsidiary Xenerex Biosciences will make human monoclonal antibodies against two antigens supplied by DNAX Research, the immunology and molecular biology research division of SGP. DNAX will evalua...